Insights

AI Biotech Advantage Debut combines AI and biotechnology to create sustainable, clinically proven ingredients for beauty, presenting a compelling value proposition for premium brands seeking innovative actives and purity.

Strategic Partnerships Ongoing collaboration with Natura Cosmeticos SA and other regional players positions Debut for faster market access, co-development opportunities, and joint go-to-market strategies in Latin America and beyond.

Longevity Focus Active development of AI-discovered skin longevity ingredients signals a clear growth vector in anti-aging formulations, aligning with premium customer demand for long-term skin health benefits.

Sustainability & Regulation Emphasis on inherently sustainable ingredients supports increasingly stringent clean beauty standards, offering a route to differentiate in channels prioritizing ESG compliance.

Diverse Revenue Avenues Beyond cosmetics, Debut’s collaboration with color technology partners for natural color solutions indicates cross-industry expansion potential and multi-product selling opportunities.

Debut Tech Stack

Debut uses 8 technology products and services including WordPress, Salesforce, Shopify, and more. Explore Debut's tech stack below.

Media & News

Debut's Email Address Formats

Debut uses at least 1 format(s):
Debut Email FormatsExamplePercentage
First@debutbiotech.comJohn@debutbiotech.com
61%
FLast@debutbiotech.comJDoe@debutbiotech.com
35%
Last@debutbiotech.comDoe@debutbiotech.com
3%
First.Last@debutbiotech.comJohn.Doe@debutbiotech.com
1%

Frequently Asked Questions

What is Debut's stock symbol?

Minus sign iconPlus sign icon
Debut is a publicly traded company; the company's stock symbol is DBTB.

What is Debut's official website and social media links?

Minus sign iconPlus sign icon
Debut's official website is debutbiotech.com and has social profiles on LinkedInCrunchbase.

How much revenue does Debut generate?

Minus sign iconPlus sign icon
As of August 2026, Debut's annual revenue is estimated to be $250M - $500M.

What is Debut's SIC code NAICS code?

Minus sign iconPlus sign icon
Debut's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Debut have currently?

Minus sign iconPlus sign icon
As of August 2026, Debut has approximately 98 employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: D. B.Founder And Managing Director, Global A&r, Début: B. S.Owner: T. C.. Explore Debut's employee directory with LeadIQ.

What industry does Debut belong to?

Minus sign iconPlus sign icon
Debut operates in the Biotechnology Research industry.

What technology does Debut use?

Minus sign iconPlus sign icon
Debut's tech stack includes WordPressSalesforceShopifyMicrosoft 365Google CloudSentryKlaviyoWistia.

What is Debut's email format?

Minus sign iconPlus sign icon
Debut's email format typically follows the pattern of First@debutbiotech.com. Find more Debut email formats with LeadIQ.

How much funding has Debut raised to date?

Minus sign iconPlus sign icon
As of August 2026, Debut has raised $86M in funding. The last funding round occurred on Aug 26, 2025 for $20M.

When was Debut founded?

Minus sign iconPlus sign icon
Debut was founded in 2019.
Debut logo

Debut

Biotechnology ResearchCalifornia, United States51-200 Employees

Debut is a mid-sized biotechnology research company based in San Diego, California, that blends artificial intelligence with biotech approaches to create cosmetic actives and formulations. It emphasizes scientifically validated, clinically proven ingredients designed for high performance and sustainability, aiming to advance beauty industry standards for potency and purity. Positioned at the intersection of biotech and cosmetics, Debut pursues rigorous science to translate discovery into practical products for diverse beauty applications.

The company serves beauty brands and product developers seeking effective, sustainable ingredients that can drive better results. It has begun partnering with Natura Cosmeticos SA to develop and bring to market an AI-discovered skin longevity ingredient for the Latin American market, with commercialization contingent on clinical validation. Debut was named one of TIME100 Most Innovative Companies in 2025, reflecting recognition of its research-driven contributions.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
DBTB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $86M

    Debut has raised a total of $86M of funding over 5 rounds. Their latest funding round was raised on Aug 26, 2025 in the amount of $20Mas a series_unknown.

  • $250M - $500M

    Debut's revenue is estimated to be in the range of $250M - $500M

Section iconFunding & Financials

  • $86M

    Debut has raised a total of $86M of funding over 5 rounds. Their latest funding round was raised on Aug 26, 2025 in the amount of $20Mas a series_unknown.

  • $250M - $500M

    Debut's revenue is estimated to be in the range of $250M - $500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.